The hematopoietic growth factors regulate the growth and differentiation of myeloid and extramedullary cells of diverse embryologic origin. Granulocyte-macrophage colony stimulating factor (GM-CSF) is a notably pleiotropic hematopoietic growth factor which is being evaluated in clinical trials designed to restore hematologic cell number and function. The effects of GM-CSF on monocyte-macrophages are particularly noteworthy. In contrast to its more restricted effects on other cell types, GM-CSF induces both growth and differentiation of macrophages. The subcellular mechanism of action of GM-CSF in target cells in general, and macrophages in particular, is unknown. We have recently examined the effect of GM-CSF on the expression of the immediate early response gene, Egr-1. The regulation of Egr-1 was selected for study because it is expressed within minutes following mitogenic stimuli, is induced by diverse stimuli in proliferating and non-proliferating (post-mitotic) cell types, and encodes a protein with three zinc finger domains which confer DNA binding and transcriptional regulatory properties. We have demonstrated that GM-CSF produces a dose-dependent increase in Egr-1 mRNA in tissue macrophages within 30 minutes through a protein kinase C-independent pathway which does not require protein synthesis. Moreover, the increase in Egr-1 mRNA induced by GM-CSF is mediated, in part, by an increase in transcription of Egr-1. In recent experiments, we have successfully transfected peritoneal macrophages with an Egr-1-chloramphenicol acetyltransferase reporter construct using DEAE-dextran. We propose to pursue these initial observations by further characterizing the mechanism of GM-CSF's effect on Egr-1 expression and to define the role of Egr-1 as a nuclear intermediary in transmitting the effect of GM-CSF on responsive cell types such as macrophages. This research proposal is comprised of three major objectives. First, we will define the cis-acting elements in the 5' region of the Egr-1 gene which enhance Egr-1 transcription in response to GM-CSF. Second, the effect of GM-CSF on the level, intracellular localization, and phosphorylation state of Egr-1 protein will be defined. Third, we will pursue two experimental approaches to determine the role of Egr-1 in transmitting the effect of GM-CSF on macrophage proliferation and function. First, we will attempt to inhibit the function of endogenous Egr-1 protein by over-expressing only the zinc finger domains of Egr-1. Second, we will attempt to decrease Egr-1 protein synthesis using anti-sense oligonucleotides. These studies are ultimately intended to provide insight into the mechanisms whereby the growth and differentiation of tissue macrophages are regulated by GM-CSF.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
7R01DK046764-02
Application #
3248113
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
1992-09-30
Project End
1995-09-29
Budget Start
1993-09-30
Budget End
1994-09-29
Support Year
2
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Yale University
Department
Type
Schools of Medicine
DUNS #
082359691
City
New Haven
State
CT
Country
United States
Zip Code
06520